Multi-cellular transitional organotypic models to investigate liver fibrosis
Source abstract
Abstract
Hepatic fibrosis is the result of wound healing and inflammation resulting in organ dysfunction. Hepatocytes, liver sinusoidal endothelial cells (LSECs), Kupffer cells (KCs), and hepatic stellate cells (HSCs) play critical roles in fibrogenesis. As the liver undergoes fibrosis, there are populations of cells that are healthy, fibrotic as well as those undergoing fibrosis. We investigated how a varying mechanical environment could induce changes in hepatic cells. In this study, a gradient in the mechanical properties of the microenvironment resulted in transitioning phenotypes in hepatic cells. We have designed detachable polyelectrolyte multilayers (PEMs) whose elastic moduli ranged from 21 to 43 kPa to serve as Space of Disse mimics. We assembled novel 3D organotypic liver models comprised of hepatocytes, LSECs, HSCs, KCs, and the Space of Disse mimic. We demonstrate how cells in contact with a mechanical gradient exhibit different properties compared to cells cultured using non-gradient PEMs. Significant differences were observed in HSC and KC proliferation between 3D cultures assembled with gradient and non-gradient PEMs. While HSCs on the stiffer regions of the gradient PEMs expressed both GFAP and α-SMA, cells in cultures assembled with homogeneous 43 kPa multilayers primarily expressed α-SMA. Over an 8-day culture, the elastic modulus in the 21 and 43 kPa regions of the gradient PEMs increased by 1.6 and 3.7-fold, respectively. This was accompanied by a 4-fold increase in hydroxyproline. Such in vitro tissues can be used to investigate the effects of liver fibrosis. STATEMENT OF SIGNIFICANCE: We have assembled a liver model assembled with four major primary hepatic cell types to investigate how a varying mechanical environment induces changes in hepatic cells. In this study, a gradient in the mechanical properties of the microenvironment results in transitioning phenotypes in hepatic cells. Our goal was to investigate the interplay between mechanical properties and a multi-cellular engineered liver tissue. In these models, Kupffer cell proliferation and hepatic stellate cell activation occurred due to mechanical cues and inter-cellular signaling across a distance of 2000 μm. These models are unique, in that, fibrosis was initiated purely through changes to the microenvironment. These models were not exposed to fibrogenic factors nor were the models assembled with cells from fibrotic rats. To the best of our knowledge, these are the first liver models that capture how a gradient microenvironment can result in transitioning cellular phenotypes.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Liver physiology and pathology · 3D Printing in Biomedical Research · Cellular Mechanics and Interactions
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (71)
Show source-provided references
1. Deaths: final data for 2014
2. Noninvasive biochemical markers of liver fibrosis
3. Liver cirrhosis10.1016/S0140-6736(08)60383-9 ↗
4. Liver fibrosis10.1172/JCI24282 ↗
5. Mechanisms of hepatic fibrogenesis10.1053/j.gastro.2008.03.003 ↗
6. Hepatic fibrosis: Concept to treatment10.1016/j.jhep.2015.02.039 ↗
7. Cellular and molecular mechanisms of fibrosis10.1002/path.2277 ↗
8. Pathogenesis of liver cirrhosis10.3748/wjg.v20.i23.7312 ↗
9. Liver fibrosis and repair: immune regulation of wound healing in a solid organ10.1038/nri3623 ↗
10. Arias · 2009
11. Mechanisms of hepatic stellate cell activation10.1038/nrgastro.2017.38 ↗
12. J. Shan, K.R. Stevens, K. Trehan, G.H. Underhill, A.A. Chen, S.N. Bhatia, Hepatic tissue engineering, in: S.P.S. Monga (ed.), Molecular Pathology of Liver Diseases, 2011, pp. 321–342.10.1007/978-1-4419-7107-4_22 ↗
13. Function and metabolism of collagen and other extracellular matrix proteins
14. Wisse · 1999
15. Structural and functional aspects of liver sinusoidal endothelial cell fenestrae: a review10.1186/1476-5926-1-1 ↗
16. Increased stiffness of the rat liver precedes matrix deposition: implications for fibrosis, American journal of physiology10.1152/ajpgi.00032.2007 ↗
17. Adverse outcome pathway development from protein alkylation to liver fibrosis10.1007/s00204-016-1814-8 ↗
18. Mechanisms of fibrosis: therapeutic translation for fibrotic disease10.1038/nm.2807 ↗
19. Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury10.1074/jbc.275.4.2247 ↗
20. Hepatic inflammation and fibrosis: functional links and key pathways10.1002/hep.27332 ↗
21. Matrix metalloproteinases, the pros and cons, in liver fibrosis
22. Expression of MMPs and TIMPs in liver fibrosis - a systematic review with special emphasis on anti-fibrotic strategies10.1016/j.jhep.2007.02.003 ↗
23. Experimental models of liver fibrosis10.1007/s00204-015-1543-4 ↗
24. The HepaRG cell line: biological properties and relevance as a tool for cell biology, drug metabolism, and virology studies10.1007/978-1-60761-688-7_13 ↗
25. Novel human hepatic organoid model enables testing of drug-induced liver fibrosis in vitro10.1016/j.biomaterials.2015.11.026 ↗
26. Modeling compound-induced fibrogenesis in vitro using three-dimensional bioprinted human liver tissues10.1093/toxsci/kfw169 ↗
27. The interplay between hepatic stellate cells and hepatocytes in an in vitro model of NASH10.1016/j.tiv.2015.07.010 ↗
28. The importance of the interaction between hepatocyte and hepatic stellate cells in fibrogenesis induced by fatty accumulation10.1016/j.yexmp.2014.12.006 ↗
29. Oxidative-stress and IL-6 mediate the fibrogenic effects of [corrected] Kupffer cells on stellate cells10.1002/hep.21427 ↗
30. Gradually softening hydrogels for modeling hepatic stellate cell behavior during fibrosis regression10.1039/C6IB00027D ↗
31. Hepatic stellate cells display a functional vascular smooth muscle cell phenotype in a three-dimensional co-culture model with endothelial cells10.1111/j.1432-0436.2007.00260.x ↗
32. Liver fibrosis in vitro: cell culture models and precision-cut liver slices10.1016/j.tiv.2006.12.009 ↗
33. Human liver slices as an in vitro model to study toxicity-induced hepatic stellate cell activation in a multicellular milieu10.1016/j.cbi.2006.05.006 ↗
34. Editor's highlight: modeling compound-induced fibrogenesis in vitro using three-dimensional bioprinted human liver tissues10.1093/toxsci/kfw169 ↗
35. Pro-fibrotic compounds induce stellate cell activation, ECM-remodelling and Nrf2 activation in a human 3D-multicellular model of liver fibrosis10.1371/journal.pone.0179995 ↗
36. Exposure of precision-cut rat liver slices to ethanol accelerates fibrogenesis, American journal of physiology10.1152/ajpgi.00287.2009 ↗
37. Acute toxicity of CCl4 but not of paracetamol induces a transcriptomic signature of fibrosis in precision-cut liver slices10.1016/j.tiv.2015.03.015 ↗
38. Models of liver fibrosis: exploring the dynamic nature of inflammation and repair in a solid organ10.1172/JCI30542 ↗
39. Molecular regulation of hepatic fibrogenesis10.1016/S0168-8278(98)80269-9 ↗
40. The design of antimicrobial LL37-modified collagen-hyaluronic acid detachable multilayers10.1016/j.actbio.2016.04.027 ↗
41. Designing a fibrotic microenvironment to investigate changes in human liver sinusoidal endothelial cell function10.1016/j.actbio.2015.06.028 ↗
42. Investigating acetaminophen hepatotoxicity in multi-cellular organotypic liver models10.1016/j.tiv.2017.03.008 ↗
43. Opposing rigidity-protein gradients reverse fibroblast durotaxis10.1021/acsbiomaterials.5b00229 ↗
44. Designing a multicellular organotypic 3D liver model with a detachable, nanoscale polymeric Space of Disse10.1089/ten.tec.2012.0700 ↗
45. A simple method for the simultaneous isolation of stellate cells and hepatocytes from rat liver tissue10.1023/A:1024184826728 ↗
46. Hepatic stellate cell lipid droplets: a specialized lipid droplet for retinoid storage10.1016/j.bbalip.2008.11.001 ↗
47. Local 3D matrix microenvironment regulates cell migration through spatiotemporal dynamics of contractility-dependent adhesions10.1038/ncomms9720 ↗
48. High-throughput toxicity testing of chemicals and mixtures in organotypic multi-cellular cultures of primary human hepatic cells10.1016/j.tiv.2018.05.006 ↗
49. Cell spreading as a hydrodynamic process10.1039/c0sm00252f ↗
50. A simplified method for the analysis of hydroxyproline in biological tissues10.1016/0009-9120(96)00003-6 ↗
51. Immunology of the healthy liver: old questions and new insights10.1053/gast.2001.20947 ↗
52. Co-culture of hepatocytes and kupffer cells as an in vitro model of inflammation and drug-induced hepatotoxicity10.1016/S0022-3549(15)00192-6 ↗
53. Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver10.1152/physrev.00013.2007 ↗
54. Anti-inflammatory and pro-inflammatory roles of TGF-beta, IL-10, and IL-22 in immunity and autoimmunity10.1016/j.coph.2009.04.008 ↗
55. Induction of apoptosis in cultured hepatocytes and in regressing liver by transforming growth factor beta 110.1073/pnas.89.12.5408 ↗
56. The extracellular matrix coordinately modulates liver transcription factors and hepatocyte morphology
57. Requirement of 3D extracellular network for maintenance of mature hepatocyte morphology and suppression of alpha-fetoprotein synthesis in vitro10.1016/S0165-2478(03)00162-7 ↗
58. Molecular mechanism responsible for fibronectin-controlled alterations in matrix stiffness in advanced chronic liver fibrogenesis10.1074/jbc.M115.691519 ↗
59. Mechanotransduction-modulated fibrotic microniches reveal the contribution of angiogenesis in liver fibrosis10.1038/nmat5024 ↗
60. Engineering in vitro models of hepatofibrogenesis10.1016/j.addr.2017.05.018 ↗
61. 3D in vitro models of liver fibrosis10.1016/j.addr.2017.07.004 ↗
62. Policy committee of the American association for the study of liver, serum activity of alanine aminotransferase (ALT) as an indicator of health and disease10.1002/hep.22109 ↗
63. Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease10.1002/hep.23312 ↗
64. In vivo mechanical characterization of human liver10.1016/j.media.2007.10.001 ↗
65. Liver stiffness: a novel parameter for the diagnosis of liver disease
66. Magnetic resonance elastography measured shear stiffness as a biomarker of fibrosis in pediatric nonalcoholic fatty liver disease10.1002/hep.29241 ↗
67. Improved noninvasive prediction of liver fibrosis by liver stiffness measurement in patients with nonalcoholic fatty liver disease accounting for controlled attenuation parameter values10.1002/hep.28843 ↗
68. Comparison of laboratory tests, ultrasound, or magnetic resonance elastography to detect fibrosis in patients with nonalcoholic fatty liver disease: A meta-analysis10.1002/hep.29302 ↗
69. Elastic modulus measurements of human liver and correlation with pathology10.1016/S0301-5629(02)00489-1 ↗
70. Liver stiffness in nonalcoholic fatty liver disease: A comparison of supersonic shear imaging, FibroScan, and ARFI with liver biopsy10.1002/hep.28394 ↗
71. Physiological ranges of matrix rigidity modulate primary mouse hepatocyte function in part through hepatocyte nuclear factor 4 alpha10.1002/hep.28450 ↗